Table 2.
Adjusted Odds of Lipid Lowering Therapy Use among children ages 8–20 between 2005 and 2010 (n=1,000,665)
| IRR | 95% CI | p-value | |
|---|---|---|---|
|
|
|||
| Age ≥ 15 years | 3.07 | (2.6–3.6) | 0.00 |
| Year | |||
| 2005 | 1.00 | -- | |
| 2006 | 0.65 | (0.5–0.9) | 0.00 |
| 2007 | 0.35 | (0.3–0.5) | 0.00 |
| 2008 | 0.90 | (0.7–1.1) | 0.40 |
| 2009 | 0.57 | (0.4–0.7) | 0.00 |
| 2010 | 0.35 | (0.3–0.5) | 0.00 |
| Male | 2.00 | (1.7–2.4) | 0.00 |
| Health Utilization 1 | |||
| Inpatient stay | 1.26 | (0.8–2.1) | 0.35 |
| Outpatient visit | 2.55 | (2.1–3.1) | 0.00 |
| Prescription Medication | 0.16 | (0.1–0.2) | 0.00 |
CI, confidence interval;
1
>1 inpatient visit in past year ≥ 5 outpatient visits ≥2 prescription drug dispensings in the last 12 months